​

Funding Round

Post-IPO Equity - LENZ Therapeutics

Post-IPO Equity - LENZ Therapeutics

Investment Firm

Overview

LENZ Therapeutics operates as an organization engaged in the late-stage clinical development of pharmaceuticals for the eyes.

Announced Date

Mar 21, 2024

Funding Type

Post Ipo Equity

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

6

Investor Name
Participant InvestorRTW Investments
Participant InvestorRA Capital Management
Participant InvestorSectoral Asset Management
Participant InvestorPoint72
Participant InvestorVersant Ventures

Round Details and Background

LENZ Therapeutics raised $53500000 on 2024-03-21 in Post-IPO Equity

LENZ Therapeutics operates as an organization engaged in the late-stage clinical development of pharmaceuticals for the eyes.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Mar 07, 2023
Series B - LENZ Therapeutics
1-83.5M
Jul 15, 2024
Post-IPO Equity - LENZ Therapeutics
1-30.0M
Mar 21, 2024
Post-IPO Equity - LENZ Therapeutics
7-53.5M
Jul 01, 2016
Venture Round - LENZ Therapeutics
-3.4M

Recent Activity

There is no recent news or activity for this profile.